CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.44B, above the global median of $1.15B
- FinancialsAltman Z-Score 7.05: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.65%Below 5Y avg (2.84%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
27.0%Sustainable
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
23.11BCNY3.44B · vs all stocks (USD)
Trailing P/E
19.83xRevenue (TTM)
8.15BCNY1.21B · vs all stocks (USD)
Profit Margin
15.01%Beta
0.2150xvs all stocks
52-Week Change
-9.37%vs all stocks
Market Capitalization
23.11BCNY3.44B · vs all stocks (USD)
Enterprise Value
29.36BCNY4.37B · vs all stocks (USD)
Trailing P/E
19.83xForward P/E
17.38xPrice to Sales (TTM)
2.84xPrice to Book (MRQ)
1.81xEnterprise to Revenue
3.60xEnterprise to EBITDA
15.52xGross Margin
71.19%Profit Margin
15.01%Operating Margin
12.83%Return on Assets (TTM)
7.20%Return on Equity (TTM)
8.81%Revenue (TTM)
8.15BCNY1.21B · vs all stocks (USD)
Revenue per Share (TTM)
5.46CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-13.50%Gross Profit (TTM)
5.41BCNY804.00M · vs all stocks (USD)
EBITDA (TTM)
1.49BCNY221.78M · vs all stocks (USD)
Net Income (TTM)
1.22BCNY181.86M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-34.20%Operating Cash Flow (TTM)
1.42BCNY211.87M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.10BCNY164.32M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.65%vs all stocks
5-Year Average Dividend Yield
2.84%vs all stocks
Payout Ratio
27.01%Minority Interest (Equity)
143.49MCNYFY2025 · Dec 31, 2025Revenue
8.24BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.73BCNYFY2025 · Dec 31, 2025Gross Profit
5.51BCNYFY2025 · Dec 31, 2025Operating Income
1.45BCNY216.29M · vs all stocks (USD)
Pre-tax Income
1.35BCNYFY2025 · Dec 31, 2025Income Tax Expense
283.89MCNYFY2025 · Dec 31, 2025Net Income
1.06BCNYFY2025 · Dec 31, 2025EBIT
1.38BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.77BCNYFY2025 · Dec 31, 2025Research & Development
685.66MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
2.03BCNYFY2025 · Dec 31, 2025Other Operating Expenses
133.94MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
58.34MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
32.50MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.49BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.49BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.06BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
43.63MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
791.24MCNYFY2025 · Dec 31, 2025Free Cash Flow
415.98MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.42BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.06BCNYFY2025 · Dec 31, 2025Other Non-cash Items
-27.61MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-522.68MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
280.20MCNYFY2025 · Dec 31, 2025Capital Expenditures
-375.26MCNYFY2025 · Dec 31, 2025Net Acquisitions
83.38MCNYFY2025 · Dec 31, 2025Purchase of Investments
-6.35BCNYFY2025 · Dec 31, 2025Sale of Investments
5.98BCNYFY2025 · Dec 31, 2025Other Investing Activity
210.49MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-446.48MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
884.39MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.51BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-632.70MCNYFY2025 · Dec 31, 2025Other Financing Charges
891.22MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-366.96MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.49BSharesUpdated Aug 20, 2026Float Shares
735.85MSharesUpdated Aug 20, 2026% Held by Insiders
52.85%vs all stocks
% Held by Institutions
5.05%vs all stocks
Total Cash (MRQ)
2.47BCNY366.63M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.65CNYUpdated Aug 20, 2026Total Debt (MRQ)
8.35BCNY1.24B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6880xCurrent Ratio (MRQ)
3.72xBook Value per Share (MRQ)
8.55CNYUpdated Aug 20, 2026Total Assets
15.34BCNY2.28B · vs all stocks (USD)
Total Current Assets
8.23BCNYFY2025 · Dec 31, 2025Total Liabilities
2.79BCNYFY2025 · Dec 31, 2025Total Non-current Assets
7.11BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
484.02MCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.31BCNYFY2025 · Dec 31, 2025Cash
1.35BCNYFY2025 · Dec 31, 2025Cash Equivalents
80.87MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.44BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.39BCNYFY2025 · Dec 31, 2025Accounts Receivable
1.12BCNYFY2025 · Dec 31, 2025Inventory
1.43BCNYFY2025 · Dec 31, 2025Accounts Payable
376.90MCNYFY2025 · Dec 31, 2025Short-term Debt
1.17BCNYFY2025 · Dec 31, 2025Other Current Liabilities
5.49MCNYFY2025 · Dec 31, 2025Long-term Debt
268.06MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.49BCNYFY2025 · Dec 31, 2025Retained Earnings
8.65BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
12.55BCNY1.87B · vs all stocks (USD)
52-Week Low
12.90CNYUpdated Aug 20, 202652-Week High
17.33CNYUpdated Aug 20, 202652-Week Change
-9.37%vs all stocks
Beta
0.2150xvs all stocks
50-Day MA
14.88CNYUpdated Aug 20, 2026200-Day MA
14.79CNYUpdated Aug 20, 2026Avg 10-Day Volume
17.16MSharesUpdated Aug 20, 2026Avg 30-Day Volume
21.92MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.7800CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 7.05: safe zoneNotable
Altman Z-Score: 7.05
High earnings qualityNotable
Earnings Quality Score: 0.51
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.44B, above the global median of $1.15BNotable
Market cap (USD): 3,436,897,272.066Global Median: 1,146,734,693.424
Revenue is $1.21B, above the global median of $520.53MNotable
Revenue (USD): 1,211,885,710.31Global Median: 520,528,949.311
Levered free cash flow is $164.32M, above the global median of $16.24MNotable
Levered free cash flow (USD): 164,318,887.867Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Nhwa Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hubei Jumpcan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Arcus Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ideaya Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Alumis Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Harbin Pharmaceutical Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hanmi Pharm Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pegbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lepu Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow